See more : Cyber Security 1 AB (publ) (CYB1.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Elanco Animal Health Inc (ELAT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Elanco Animal Health Inc, a leading company in the industry within the sector.
You may be interested
- SynAct Pharma AB (SYNACT.ST) Income Statement Analysis – Financial Results
- Shinsei Bank, Limited (8303.T) Income Statement Analysis – Financial Results
- Jiangsu Yangdian Science & Technology Co. Ltd. (301012.SZ) Income Statement Analysis – Financial Results
- F.C.C. Co., Ltd. (FCVFF) Income Statement Analysis – Financial Results
- CPL Group Public Company Limited (CPL.BK) Income Statement Analysis – Financial Results
Elanco Animal Health Inc (ELAT)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.42B | 4.42B | 4.77B | 3.27B | 3.07B | 3.07B | 2.89B | 2.91B | 2.91B |
| Cost of Revenue | 2.48B | 1.91B | 2.13B | 1.67B | 1.47B | 1.57B | 1.49B | 1.41B | 1.53B |
| Gross Profit | 1.94B | 2.51B | 2.63B | 1.61B | 1.60B | 1.49B | 1.40B | 1.50B | 1.38B |
| Gross Profit Ratio | 43.88% | 56.70% | 55.22% | 49.09% | 52.12% | 48.68% | 48.29% | 51.64% | 47.28% |
| Research & Development | 327.00M | 321.00M | 369.00M | 327.00M | 270.10M | 246.60M | 251.70M | 265.80M | 291.00M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 996.60M | 760.20M | 735.20M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 996.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.29B | 1.27B | 1.40B | 1.99B | 760.20M | 735.20M | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 528.00M | 556.00M | -636.10M | 200.40M | 197.40M | 1.00B | 955.50M | 1.08B |
| Operating Expenses | 1.61B | 2.12B | 2.33B | 1.68B | 1.23B | 1.18B | 1.25B | 1.22B | 1.37B |
| Cost & Expenses | 4.09B | 4.03B | 4.46B | 3.35B | 2.70B | 2.75B | 2.75B | 2.63B | 2.90B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 277.00M | 241.00M | 236.00M | 149.80M | 78.90M | 29.60M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 694.00M | 528.00M | 716.00M | 516.90M | 314.50M | 296.00M | 318.40M | 254.40M | 236.90M |
| EBITDA | 326.00M | 703.00M | 385.00M | -5.30M | 471.60M | 439.70M | 85.80M | 232.00M | -22.60M |
| EBITDA Ratio | 7.38% | 15.91% | 8.08% | -0.16% | 15.36% | 14.34% | 2.97% | 7.96% | -0.78% |
| Operating Income | 326.00M | 175.00M | -331.00M | -76.80M | 370.00M | 313.80M | 142.40M | 283.20M | 5.40M |
| Operating Income Ratio | 7.38% | 3.96% | -6.95% | -2.35% | 12.05% | 10.23% | 4.93% | 9.72% | 0.19% |
| Total Other Income/Expenses | -1.52B | -450.00M | -236.00M | -595.20M | -291.80M | -199.70M | -375.00M | -305.60M | -264.90M |
| Income Before Tax | -1.20B | -66.00M | -567.00M | -672.00M | 78.20M | 114.10M | -232.60M | -22.40M | -259.50M |
| Income Before Tax Ratio | -27.05% | -1.49% | -11.90% | -20.53% | 2.55% | 3.72% | -8.05% | -0.77% | -8.92% |
| Income Tax Expense | 36.00M | 8.00M | -95.00M | -111.90M | 10.30M | 27.60M | 78.10M | 25.50M | -48.70M |
| Net Income | -1.23B | -74.00M | -472.00M | -560.10M | 67.90M | 86.50M | -310.70M | -47.90M | -210.80M |
| Net Income Ratio | -27.87% | -1.67% | -9.91% | -17.11% | 2.21% | 2.82% | -10.75% | -1.64% | -7.25% |
| EPS | -2.50 | -0.15 | -0.96 | -1.14 | 0.14 | 0.18 | -0.64 | 0.00 | 0.00 |
| EPS Diluted | -2.50 | -0.15 | -0.96 | -1.14 | 0.14 | 0.18 | -0.63 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 492.30M | 488.30M | 492.00M | 492.00M | 492.00M | 492.00M | 488.00M | 0.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 492.30M | 488.30M | 492.00M | 492.00M | 492.00M | 492.00M | 492.00M | 0.00 | 0.00 |
No news found for: ELAT
Source: https://incomestatements.info
Category: Stock Reports